home / lobbying

lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

260 rows where filing_period = "second_quarter", filing_year = 2012 and issue_code = "MED" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: filing_type, income_amount, is_termination, received_date (date)

issue_code 1

  • MED · 260 ✖

filing_year 1

  • 2012 · 260 ✖

filing_period 1

  • second_quarter · 260 ✖
id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
1257142 CHARLIE MCBRIDE ASSOCIATES 015062f9-4831-447e-894d-380818b6a2e1 Q2 CHARLIE MCBRIDE ASSOCIATES 24214 BIOMEDICAL RESEARCH FOUNDATION OF NORTHWEST LOUISIANA 2012 second_quarter MED To monitor legislation affecting medical energy research and technology-based economic development HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2012-06-15T15:46:44.583000-04:00
1257174 OGR a70765b0-41d2-4a68-b37d-0e0d42b2def1 Q2 OGR 48827 ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED) 2012 second_quarter MED Medical Device User Fee Act and related issues HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2012-06-18T11:03:32.377000-04:00
1257486 PARALYZED VETERANS OF AMERICA 4c3adf07-bee6-4ab8-ab58-526bb8b7b69e Q2 PARALYZED VETERANS OF AMERICA 30724 PARALYZED VETERANS OF AMERICA 2012 second_quarter MED Department of Veterans Affairs, Medical Research Issues National Institutes of Health, Medical Research Issues HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Institutes of Health (NIH),SENATE,Veterans Affairs, Dept of (VA)   83249 0 0 2012-06-29T11:27:08.117000-04:00
1257869 RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) 340b4753-f1a3-4e66-8f94-074a909d1181 Q2 RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) 400361684 VIJUK EQUIPMENT, INC. 2012 second_quarter MED all matters dealing with pharmaceutical labeling Food & Drug Administration (FDA) 25000   0 0 2012-07-03T10:25:36.937000-04:00
1257896 ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) 6dc668bf-df49-4fdf-a1fd-fbcccb1db8c3 Q2 ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) 1466 ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) 2012 second_quarter MED AACC contacted House leaders to support provisions Sections 721 and 203(f) of H.R.5651, Food and Drug Administration Reform Act of 2012, which sought to streamline the FDA de novo medical device review process and give the HHS Secretary authority to waive FDA medical device user fees in the interest of public health. HOUSE OF REPRESENTATIVES,SENATE     0 0 2012-07-03T10:56:49.673000-04:00
1258012 WAKE FOREST UNIVERSITY HEALTH SCIENCES badf2a52-a5cd-4e7d-ac05-1f55de0a6804 Q2 WAKE FOREST UNIVERSITY HEALTH SCIENCES 6781 WAKE FOREST UNIVERSITY HEALTH SCIENCES 2012 second_quarter MED NIH Budget including Title VII & VIII programs VA-Outpatient Clinic in N.C.(RFP-land acquisition) Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)   145000 0 0 2012-07-03T13:43:15.167000-04:00
1258099 UNIVERSITY OF IOWA d38dbbed-253f-4ab8-a41a-f0a1eb5e397c Q2 UNIVERSITY OF IOWA 49191 UNIVERSITY OF IOWA 2012 second_quarter MED FY 2011 Appropriations Residency Caps FY 2012 Appropriations Minority Improvement Medical Affordability Act False Claims Correction Act Research Misconduct Clinical Trials NIOSH Education and Research Centers for Occupational Health and Safety Pathways for Biosimilars Act Prevention Research Centers Resident Physician Shortage Health Care Reform FY 2013 Appropriations Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT)   88684 0 0 2012-07-03T16:59:14.913000-04:00
1258217 THE HARRIS FIRM 783a0b90-0c66-44b7-9343-5d1fee453509 Q2 THE HARRIS FIRM 68376 DIRECT MESSAGE LAB 2012 second_quarter MED Regarding funding pertaining to software communication system for chronic disease management. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE     0 0 2012-07-05T12:51:47.947000-04:00
1258258 MARSHALL BRACHMAN 40042197-7268-418b-a143-3d12806d5ae0 Q2 MARSHALL BRACHMAN 6848 BAYLOR SCOTT AND WHITE HEALTH -- FORMERLY BAYLOR HEALTH CARE SYSTEM 2012 second_quarter MED support funding for medical research programs HOUSE OF REPRESENTATIVES,SENATE 33000   0 0 2012-07-05T13:48:06.717000-04:00
1258286 STANFORD UNIVERSITY 83ea2395-df24-4c53-9618-3098df517882 Q2 STANFORD UNIVERSITY 36492 STANFORD UNIVERSITY 2012 second_quarter MED Stem Cell Research Policy HR2376 Stem Cell Research Advancement Act Defense, Dept of (DOD),Energy, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),Office of Science & Technology Policy (OSTP),SENATE   100000 0 0 2012-07-05T14:05:17.880000-04:00
1258379 AMERICAN COLLEGE OF CLINICAL PHARMACY 8d8da5a7-ba19-4f0b-8d4d-e341a6483704 Q2 AMERICAN COLLEGE OF CLINICAL PHARMACY 57258 AMERICAN COLLEGE OF CLINICAL PHARMACY 2012 second_quarter MED Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   61700 0 0 2012-07-05T15:08:09.390000-04:00
1258511 FEDERAL SOLUTIONS, LLC a7cac74b-e5af-4549-8507-b113423cc1f7 Q2 FEDERAL SOLUTIONS, LLC 311371 JACKSONVILLE STATE UNIVERSITY 2012 second_quarter MED Labor/HHS/Education Appropriations Bill 2012: Provisions relating to disease research, education, and development HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2012-07-06T10:32:18.643000-04:00
1258530 FEDERAL SOLUTIONS, LLC 0887054f-fef8-4183-9a70-b04e06be663c Q2 FEDERAL SOLUTIONS, LLC 311371 MISSISSIPPI STATE UNIVERSITY 2012 second_quarter MED Labor/HHS/Education Appropriations Bill 2012: Provisions relating to disease research Agriculture, Dept of (USDA),Education, Dept of,HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Oceanic & Atmospheric Administration (NOAA),SENATE 50000   0 0 2012-07-06T10:35:21.627000-04:00
1258741 FRANCIS EDWARD & CRONIN, INC. 4d07dc8a-8c0d-48bc-92bc-e31b54c23818 Q2 FRANCIS EDWARD & CRONIN, INC. 311314 CURE ALZHEIMER'S FUND 2012 second_quarter MED Legislation and issues related to Alzheimer's Disease Research Defense, Dept of (DOD),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Natl AIDS Policy,Office of Science & Technology Policy (OSTP),SENATE,White House Office 10000   0 0 2012-07-08T16:38:00.400000-04:00
1259461 RAY C CULVER III 2289e79a-388c-495e-bee0-743252b7a1a9 Q2 RAY C CULVER III 11468 ARKANSAS CHILDREN'S HOSPITAL 2012 second_quarter MED Funding for USDA Agricultural Research Service human nutrition centers in the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Bill, 2013, and authorization language in the Senate Agriculture Reform, Food and Jobs Act of 2012 and the House Federal Agriculture Reform and Risk Management Act of 2012 HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2012-07-10T00:11:55.970000-04:00
1259911 PALMETTO GROUP 62968d14-bf89-4a3c-b906-4ad986803af1 Q2 PALMETTO GROUP 18570 INTERNATIONAL AIDS VACCINE INITIATIVE 2012 second_quarter MED Federal Funding of AIDS vaccine S.1601 Department of State, Foreign Operations, and Related Programs Appropriations Act, 2012 SENATE 22500   0 0 2012-07-10T16:15:07.037000-04:00
1260174 KSCW, INC. 6efba89e-0c2c-4032-907b-51ef9c548cf6 Q2 KSCW, INC. 21596 INTERNATIONAL ASSOCIATION OF MEDICAL EQUIPMENT REMARKETERS AND SERVICERS (IAMERS 2012 second_quarter MED S.3187: Food and Drug Administration Safety and Innovation Act, Provisions affecting the Medical device industry H.R.436: Health Care Cost Reduction Act of 2012 provisions related to the medical device excise tax S.262 A bill to repeal the excise tax on medical device manufacturers. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2012-07-11T11:05:43.703000-04:00
1260654 DENNY MILLER ASSOCIATES bdd45747-b59c-495d-8596-8f713efb7291 Q2 DENNY MILLER ASSOCIATES 25328 CELL THERAPEUTICS 2012 second_quarter MED S. 3187, Food and Drug Administration Safety and Innovation Act of 2012, provisions relating to the approval of new drugs. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-07-11T16:22:16.397000-04:00
1260661 PARRY, ROMANI, DECONCINI & SYMMS 67ab2707-0f05-48ae-a31e-862816c93828 Q2 PARRY, ROMANI, DECONCINI & SYMMS 30792 AIDS HEALTHCARE FOUNDATION 2012 second_quarter MED Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012 - Support funding for medical treatment for HIV positive patients. Support appropriate funding for the ADAP program. Continue appropriate funding for Chronic Care Special Needs clinics under Medicare. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-07-11T16:35:20.333000-04:00
1260840 THE PETRIZZO GROUP, INC. 718fe664-97b0-4483-9409-8cfcc7e3ba32 Q2 THE PETRIZZO GROUP, INC. 305932 FRED HUTCHINSON CANCER RESEARCH CENTER 2012 second_quarter MED Advocated for funding for the National Institutes of Health and National Cancer Institute for FY 2013 funding. Advocated for funding by USAID for the Uganda Program on Cancer & Infectious Diseases. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2012-07-12T09:49:14.003000-04:00
1260858 TAUZIN CONSULTANTS, LLC f87f2484-6678-45f8-8c02-9b62094936a9 Q2 TAUZIN CONSULTANTS, LLC 400671007 RESILIENT NETWORK SYSTEMS, INC. 2012 second_quarter MED Cross-agency research and collaboration for R&D, clinical trials and recruitment. Director of National Intelligence (ODNI),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 10000   0 0 2012-07-12T09:59:11-04:00
1260868 THE PETRIZZO GROUP, INC. 01e51ac6-10b7-4923-9b8f-526051e95362 Q2 THE PETRIZZO GROUP, INC. 305932 MVP SERVICE CORP. 2012 second_quarter MED Advocated concerns with negative consequences of the Patient Protection and Affordable Care Act (ACA), specifically 1) new taxes that will cause premium increases and raise cost of health care coverage; 2) cuts to Medicare Advantage funding; 3)weak individual mandate resulting in adverse selection; 4) HHS proposed regulation that omits fraud and abuse prevention, concurrent review and costs associated with the federally-mandated ICD-10 program from health care quality improvement programs. Encouraged Members to co-sponsor a bill (H.R. 1370) introduced by Representative Boustany (R-LA) that would repeal the Small-Business Health Insurance Tax (HIT) enacted by the Affordable Care Act (ACA). Raised awareness about the impact of significant funding cuts included in the ACA and encourages Congress to restore the MA program funding to pre-ACA levels. Encouraged Members to co-sponsor the bipartisan Medicare Beneficiary Preservation Act of 2011 (H.R. 1580/S. 1479), which was introduced by Representatives Gonzalez (D-TX) and Buchanan (R-FL) and Senators Casey (D-PA) and Toomey (R-PA). This bill would provide a backstop for Medicare enrollees to find a suitable health plan by repealing ACA changes to MA open enrollment dates that limit beneficiary choice and flexibility. The bill would also lengthen open enrollment periods and allowas was the case before ACA changesenrollees to change from an MA plan to the original fee-for-service plan, or vice versa, or to a more suitable MA plan once a year during the first three months. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2012-07-12T10:03:29.683000-04:00
1260885 THE PETRIZZO GROUP, INC. 55ad924c-2a70-494a-b54e-19155286021c Q2 THE PETRIZZO GROUP, INC. 305932 ORLANDO HEALTH 2012 second_quarter MED Concerns with issues around the Medicaid expansion of the ACA and Disproportionate Share Hospital (DSH) cuts. Concerns with issues regarding Medicaid being used as an offset for tax cuts and sequestration. HOUSE OF REPRESENTATIVES 30000   0 0 2012-07-12T10:12:43.243000-04:00
1260895 THE PETRIZZO GROUP, INC. 8f911f37-f8f9-4586-a0cb-15d9cc2d3782 Q2 THE PETRIZZO GROUP, INC. 305932 SAGE THERAPEUTICS, INC. 2012 second_quarter MED Advocated for federal funding to support development of neuroactive steroids research yielding therapeutics with a core focus on Traumatic Brain Injury (TBI), Post-Traumatic Stress Disorder (PTSD), and Pain. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-07-12T10:23:48.893000-04:00
1261074 TURNER & GOSS LLP d15a28bd-b85a-4687-9020-4ab15ad7971f Q2 TURNER & GOSS LLP 316310 CYSTIC FIBROSIS FOUNDATION 2012 second_quarter MED Food and Drug Administration Safety and Innovation Act, including provisions of the Expanding and Promoting Exertise in Review of Rare Treatments Act of 2012 (S. 2281/HR 4156) as incorporated in the Act HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2012-07-12T12:35:32.277000-04:00
1261079 TURNER & GOSS LLP b23da46a-4741-474e-a9be-6819748f42c9 Q2 TURNER & GOSS LLP 316310 CANCER LEADERSHIP COUNCIL 2012 second_quarter MED Drug shortage provisions as included in the Food and Drug Administration Safety and Innovation Act HOUSE OF REPRESENTATIVES,SENATE     0 0 2012-07-12T12:40:36.023000-04:00
1261081 TURNER & GOSS LLP 59196aab-e20d-4c3e-a13a-5eb064fe38d8 Q2 TURNER & GOSS LLP 316310 LYMPHOMA RESEARCH FOUNDATION 2012 second_quarter MED Drug shortage provisions of the Food and Drug Administration Safety and Innovation Act HOUSE OF REPRESENTATIVES,SENATE     0 0 2012-07-12T12:45:36.867000-04:00
1261089 TURNER & GOSS LLP 691a1173-9935-4156-97c1-cce7f776c496 Q2 TURNER & GOSS LLP 316310 LEUKEMIA & LYMPHOMA SOCIETY 2012 second_quarter MED Drug shortage provisions of Food and Drug Administration Safety and Innovation Act HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2012-07-12T12:51:40.520000-04:00
1261091 TURNER & GOSS LLP f0f95e7e-48b5-426d-9aa0-8c575f017808 Q2 TURNER & GOSS LLP 316310 NATIONAL COALITION FOR CANCER SURVIVORSHIP 2012 second_quarter MED Drug shortage provisions of Food and Drug Administration Safety and Innovation Act HOUSE OF REPRESENTATIVES,SENATE     0 0 2012-07-12T12:57:42.457000-04:00
1261135 THOMPSON HINE LLP 23274b52-57a1-423b-89b2-8c97d8e75830 Q2 THOMPSON HINE LLP 38051 TEXAS BIOMEDICAL RESEARCH INSTITUTE 2012 second_quarter MED Legislative and regulatory matters regarding the use of chimpanzees in biomedical research (i.e., the Great Ape Protection and Cost Savings Act and possible "endangered species" designation for chimpanzees by the U.S. Fish and Wildlife Service). HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2012-07-12T14:20:07.780000-04:00
1261292 PARRY, ROMANI, DECONCINI & SYMMS e2fa8db2-aa81-42ad-9ace-ec874e6285b7 Q2 PARRY, ROMANI, DECONCINI & SYMMS 30792 BRAIDWOOD MANAGEMENT, INC. 2012 second_quarter MED Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2012-07-12T16:58:31.483000-04:00
1261301 PARRY, ROMANI, DECONCINI & SYMMS ef702ed0-4326-44a6-aabd-1688e8451258 Q2 PARRY, ROMANI, DECONCINI & SYMMS 30792 DIAMONDBACK DRUGS 2012 second_quarter MED Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. HOUSE OF REPRESENTATIVES,SENATE 6000   0 0 2012-07-12T17:05:35.747000-04:00
1261350 PARRY, ROMANI, DECONCINI & SYMMS bbf34b52-4b5b-4173-a16b-68ba45116eb9 Q2 PARRY, ROMANI, DECONCINI & SYMMS 30792 VETERINARY PHARMACIES OF AMERICA, INC. 2012 second_quarter MED Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2012-07-12T17:25:57.753000-04:00
1261377 PARRY, ROMANI, DECONCINI & SYMMS 347c89ec-f95a-41a1-a32d-649aa6766f94 Q2 PARRY, ROMANI, DECONCINI & SYMMS 30792 WEDGEWOOD VILLAGE PHARMACY, INC. 2012 second_quarter MED Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2012-07-12T17:33:07.937000-04:00
1261392 PARRY, ROMANI, DECONCINI & SYMMS 52b94dbf-16a3-4867-840f-7092121257d9 Q2 PARRY, ROMANI, DECONCINI & SYMMS 30792 WOMEN'S INTERNATIONAL PHARMACY, INC. 2012 second_quarter MED Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2012-07-12T17:41:15.013000-04:00
1261565 BEN BARNES GROUP LP 68a55e10-2c50-4c0a-b211-bd34a8be5cba Q2 BEN BARNES GROUP LP 5415 FAIR LABORATORY PRACTICES ASSOCIATION 2012 second_quarter MED Bring attention to prevention of unfair billing practices by laboratories for Medicare services HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2012-07-13T09:47:19.770000-04:00
1261844 DALRYMPLE & ASSOCIATES, LLC 0c66fce2-9a02-407c-8df7-5bee6d470ea1 Q2 DALRYMPLE & ASSOCIATES, LLC 5073 SANOFI PASTEUR 2012 second_quarter MED Vaccine research and development legislation, funding, appropriations and oversight. Army, Dept of (Other),Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,State, Dept of (DOS),U.S. Agency for International Development (USAID),Veterans Affairs, Dept of (VA),White House Office 46000   0 0 2012-07-13T11:53:18.190000-04:00
1261876 DALRYMPLE & ASSOCIATES, LLC bcd3e5dd-ccc5-427d-8d6e-6274a7b86baf Q2 DALRYMPLE & ASSOCIATES, LLC 5073 EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) 2012 second_quarter MED Biodefense and naturally-occurring vaccine and related biological therapeutic products and civilian oncology therapeutic products research and development funding, legislation, appropriations and oversight. Army, Dept of (Other),Ballistic Missile Defense Organization,Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office 46000   0 0 2012-07-13T11:59:31.250000-04:00
1261909 DALRYMPLE & ASSOCIATES, LLC f2d03b67-cecb-4e64-9c17-7ae4d0b6c23b Q2 DALRYMPLE & ASSOCIATES, LLC 5073 DISCOVERY LABORATORIES 2012 second_quarter MED Small peptide synthetic lung surfactant and medical device delivery medical countermeasures against CBRN threats research and development grant and contract funding opportunities, legislation, appropriations and oversight. Army, Dept of (Other),Ballistic Missile Defense Organization,Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office 16000   0 0 2012-07-13T12:04:40.623000-04:00
1262275 BEN BARNES GROUP LP ccac1488-5052-4a7a-b5cb-70fd0390d5d1 Q2 BEN BARNES GROUP LP 5415 OKLAHOMA RESEARCH MEDICAL FOUNDATION 2012 second_quarter MED Medical Research Funding HOUSE OF REPRESENTATIVES,SENATE 20100   0 0 2012-07-13T15:12:11.107000-04:00
1262547 OREGON STATE UNIVERSITY 4cc70a7f-baab-41cc-ac56-77116e49a2a0 Q2 OREGON STATE UNIVERSITY 309390 OREGON STATE UNIVERSITY 2012 second_quarter MED HR 3433, the GRANT Act- advocated for a balanced approach to publication of competitive grant proposals and processes. S. 968, the Protect IP Act and HR 3261 the Stop Online Privacy Act. H.R.5037 or S.1373 the Federal Research Public Access Act.Data Act 2146. HOUSE OF REPRESENTATIVES,SENATE   40000 0 0 2012-07-13T17:23:56.943000-04:00
1262557 BEN BARNES GROUP LP c2e5bb4a-fe59-4b3f-b502-98c5fc48b637 Q2 BEN BARNES GROUP LP 5415 ROYALTY PHARMA - / RP MANAGEMENT, LLC 2012 second_quarter MED Matters pertaining to the Stop Internet Piracy Act and other legislation related to internet security HOUSE OF REPRESENTATIVES,SENATE 150000   0 0 2012-07-13T17:25:58.570000-04:00
1262680 SQUIRE PATTON BOGGS 29214ecf-1260-4c3d-928f-e74f59eac9e2 Q2 SQUIRE PATTON BOGGS 30906 GENENTECH, INC. 2012 second_quarter MED Implementation of healthcare reform law. FDA drug approval and appeal oversight process. Issues related to patient and physician choice in medical treatments. PDUFA reauthorization. HOUSE OF REPRESENTATIVES,SENATE 90000   0 0 2012-07-14T10:04:28.880000-04:00
1262744 BEN BARNES GROUP LP 07968fd8-02da-4632-8363-4789058ee15d Q2 BEN BARNES GROUP LP 5415 TEXAS A&M SYSTEM 2012 second_quarter MED Assist the Texas A&M System in pursuit of various projects, general government relations Education, Dept of,HOUSE OF REPRESENTATIVES,SENATE 37500   0 0 2012-07-14T12:13:20.810000-04:00
1262915 BRACEWELL LLP 9b2b7715-455c-4f98-a87f-9f7bf126eb4a Q2 BRACEWELL LLP 6837 AIR LIQUIDE USA LLC 2012 second_quarter MED Worked related to the Medical Gas Safety Act Energy, Dept of,Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),SENATE,Treasury, Dept of 60000   0 0 2012-07-15T13:17:34.087000-04:00
1263258 VAN SCOYOC ASSOCIATES 33a9b221-9a08-4b59-8a14-7451a3c1a136 Q2 VAN SCOYOC ASSOCIATES 39837 ELECTROCHEMICAL OXYGEN CONCEPTS, INC. DBA EO2 CONCEPTS 2012 second_quarter MED No lobbying activity. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2012-07-16T06:30:12.037000-04:00
1263381 VAN SCOYOC ASSOCIATES 43acb245-ed68-4331-a035-8df106f6094d Q2 VAN SCOYOC ASSOCIATES 39837 MEDICINES FOR MALARIA VENTURE 2012 second_quarter MED USAID and Malaria research and development issues and initiatives HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-07-16T07:20:00.197000-04:00
1263528 VENABLE LLP 765e2462-8937-46b3-81fa-288d54b95ac4 Q2 VENABLE LLP 39941 AMPHASTAR PHARMACEUTICALS INC. 2012 second_quarter MED Primatene Mist Sunset Date Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-07-16T08:50:38.570000-04:00
1263663 CORNERSTONE GOVERNMENT AFFAIRS, INC. c6ac1098-c908-466c-992e-8a42b1033920 Q2 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 PATH 2012 second_quarter MED Monitor issues related to global health and technology. Track USG activity and expenditures on medical research and development. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2012-07-16T10:02:48.663000-04:00
1263679 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. c45c6b19-63cc-43d3-b377-73f1d86e899b Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 TUBEROUS SCLEROSIS ALLIANCE 2012 second_quarter MED No Bill #, Labor-HHS-Education Appropriations Bill, FY 2013, Tuberous Sclerosis HR 5856, Defense Appropriations, FY 2013 Defense health programs, Tuberous Sclerosis Complex Research Program Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 20000   0 0 2012-07-16T10:09:59.383000-04:00
1263719 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 4a79cc1a-d64d-481d-8f66-28bfb8e5317b Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 SAGE PUBLICATIONS, INC. 2012 second_quarter MED HR4004, S.2096, Federal Research Public Access Act; National Institutes of Health Open Access policy No Bill#, America COMPETES Act, implementation of public access policy at federal science agencies No Bill #, Labor-HHS-Education Appropriations Bill, FY 2013, NIH Open Access Policy, Department of Education Title II Funding HR3699, Research Works Act No Bill#, Reauthorization of Elementary and Secondary Education Act, Title II Funding HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2012-07-16T10:24:14.573000-04:00
1263819 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. a56f7bf4-404c-48fd-9639-7e29af43d297 Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 APLASTIC ANEMIA & MDS INTERNATIONAL FOUNDATION 2012 second_quarter MED No Bill #, Labor-HHS-Education Appropriations Bill, FY 2013, biomedical research HR 5856, Defense Appropriations Bill, FY 2013, defense health programs, research for bone marrow failure disease HR 640, Bone Marrow Failure Disease Research and Treatment Act Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 20000   0 0 2012-07-16T11:08:58.627000-04:00
1263825 SRI INTERNATIONAL ccbeb09c-fb48-45b8-9ec8-a5d7974f3e8e Q2 SRI INTERNATIONAL 90990 SRI INTERNATIONAL 2012 second_quarter MED Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 (HR 2405, S 1855) FY 13 House and Senate Labor/HHS/Education Appropriations (S 3295) HOUSE OF REPRESENTATIVES,SENATE   90000 0 0 2012-07-16T11:10:00.770000-04:00
1263867 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 43c02fe4-5b81-4539-9889-17e4e4b13622 Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 ASSOCIATION FOR MOLECULAR PATHOLOGY 2012 second_quarter MED Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests, DNA patents, workforce issues, standards development for diagnostics. No Bill#: Genomics and Personalized Medicine Act; No Bill#: Genomic Research and Accessibility Act; No Bill#: BETTER Patient Care; HR 3207: Modernizing Laboratory Test Standards for Patients Act; HR 3497 MODDERN Cures Act Agency for Healthcare Research & Quality (AHRQ),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Patent & Trademark Office (PTO),SENATE 30000   0 0 2012-07-16T11:26:25.080000-04:00
1264069 MEHLMAN CONSULTING, INC. a40be5bb-9281-4015-b028-b45344fa5a88 Q2 MEHLMAN CONSULTING, INC. 284950 AMERICAN CLINICAL LABORATORY ASSOCIATION 2012 second_quarter MED Health reform law implementation issues including application of medical device tax to clinical laboratory tests and laboratory fee schedule. In-office ancillary services exception to Stark Law. H.R. 3207, The Modernizing Laboratory Test Standards for Patients Act. H.R. 5651, Food and Drug Administration Reform Act S. 3187, Food and Drug Administration Safety and Innovation Act. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE 60000   0 0 2012-07-16T13:15:06.857000-04:00
1264100 TCH GROUP, LLC 9dfb87db-be69-4803-8436-3e52bf5fd892 Q2 TCH GROUP, LLC 51478 SANOFI US SERVICES INC (FORMERLY KNOWN AS SANOFI-AVENTIS U S INC ) 2012 second_quarter MED General discussion regarding the reauthorization of the Prescription Drug User Fee Act (PDUFA) HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2012-07-16T13:26:26.327000-04:00
1264117 GRIZZLE COMPANY bbc59413-d265-469a-aef5-448990a48f1f Q2 GRIZZLE COMPANY 16987 UNIVERSITY OF LOUISVILLE 2012 second_quarter MED Request support for NIH grant application   40000   0 0 2012-07-16T13:32:38.440000-04:00
1264176 DIALYSIS PATIENT CITIZENS a513eaac-6ed7-4c60-a5d7-ca8d8ebd5d44 Q2 DIALYSIS PATIENT CITIZENS 400460287 DIALYSIS PATIENT CITIZENS 2012 second_quarter MED Supporting innovative pilots to reduce and potentially prevent ESRD Importance of anemia management for ESRD patients Prioritizing patient role in infection prevention efforts at dialysis facilities Prioritize patient safety in developing procedure for approval of "generic" IV Iron Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Treasury, Dept of,Veterans Affairs, Dept of (VA),White House Office   25000 0 0 2012-07-16T13:54:05.347000-04:00
1264277 MEHLMAN CONSULTING, INC. bd5f104d-08e6-49ee-822f-23efecfa8f22 Q2 MEHLMAN CONSULTING, INC. 284950 NATIONAL VENTURE CAPITAL ASSOCIATION 2012 second_quarter MED FDA reform: Changes to PDUFA (Prescription Drug User Fee Act) and MDUFA (Medical Device User Fee Act) programs. H.R. 4132, Faster Access to Specialized Treatments (FAST) Act; S. 2113, Transforming the Regulatory Environment to Accelerate Access to Treatments (TREAT) Act; H.R. 2182, Generating Antibiotic Incentives Now (GAIN) Act of 2011; S. 2236, Advancing Breakthrough Therapies for Patients Act of 2012 (See continuation page) H.R. 5651, Food and Drug Administratioin Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. Executive Office of the President (EOP),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE,Treasury, Dept of 60000   0 0 2012-07-16T14:23:54.053000-04:00
1264296 DANIELLE ORGAN PETERS ea847f0c-2aec-43ea-9d2b-58188e35f6fd Q2 DANIELLE ORGAN PETERS 400427062 FABIANI & COMPANY ON BEHALF OF MEDICAGO 2012 second_quarter MED Influenza vaccine R&D and production HOUSE OF REPRESENTATIVES,SENATE     0 0 2012-07-16T14:32:04.117000-04:00
1264592 AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS bfd4bd2d-6401-4cd0-9069-5a1fc4dfcce2 Q2 AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS 1375 AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS 2012 second_quarter MED Improving health quality measures and enhancing the activities of the Agency for Health Research and Quality (AHRQ) Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Natl Institutes of Health (NIH),SENATE   156340 0 0 2012-07-16T15:58:45.243000-04:00
1264620 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 9f454ef9-b9a3-4905-b681-c0bdf13bdcb5 Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 STATE UNIVERSITY SYSTEM OF FLORIDA 2012 second_quarter MED Appropriations and Authorization legislation for FY 2013 in health care Agriculture, Dept of (USDA),Defense, Dept of (DOD),Education, Dept of,Energy, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Interior, Dept of (DOI),SENATE 70000   0 0 2012-07-16T16:03:58.797000-04:00
1264631 LIFE TECHNOLOGIES CORPORATION bfade1d7-9636-4531-82b5-d47d0c50fdad Q2 LIFE TECHNOLOGIES CORPORATION 400391833 LIFE TECHNOLOGIES CORPORATION 2012 second_quarter MED H.R. 3207: Modernizing Laboratory Test Standards for Patients Act of 2011; Provisions regarding lab developed tests. Draft guidance regarding Commercially Distributed In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only: Frequently Asked Questions; Provisions regarding FDA regulation of certain diagnostics. HOUSE OF REPRESENTATIVES,SENATE   185000 0 0 2012-07-16T16:06:03.223000-04:00
1264667 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 59cf3bcb-a908-46a4-8754-9dc36df67f18 Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 TETHYS BIOSCIENCE 2012 second_quarter MED Regulation and reimbursement of laboratory developed tests. Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-07-16T16:17:21.067000-04:00
1264713 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. edca2026-adac-45ad-a597-a6c424dae5f5 Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 INTERNATIONAL MYELOMA FOUNDATION 2012 second_quarter MED HR 2746 Cancer Drug Coverage Parity Act; HR 2245/S.296 Preserving Access to Lifesaving Medications Act S.3187, Food and Drug Administration Safety and Innovation Act HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-07-16T16:31:41.907000-04:00
1264723 ASSN OF MEDICAL DEVICE REPROCESSORS 3ef1da76-822d-4fdb-a7b9-d93f59bc382d Q2 ASSN OF MEDICAL DEVICE REPROCESSORS 291732 ASSN OF MEDICAL DEVICE REPROCESSORS 2012 second_quarter MED Educated Congressional staff, members of Congress, and other agency officials on the FDA-regulated, third-party reprocessing industry and ongoing efforts to implement similar regulations internationally. Initiated discussions on MDUFA reauthorization. Contacted VA about hospital regulations for reprocessed single-use medical devices. Commerce, Dept of (DOC),Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE,U.S. International Trade Commission (ITC),Veterans Affairs, Dept of (VA)   20000 0 0 2012-07-16T16:31:44.797000-04:00
1264825 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 7ce30cde-4670-4055-b9c3-f12f89394f7b Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 NATIONAL ASSOCIATION OF EPILEPSY CENTERS 2012 second_quarter MED Research and public health programs in epilepsy. Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 5000   0 0 2012-07-16T16:46:36.520000-04:00
1264858 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. fb172deb-3185-4363-8eb0-675d68616c1e Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 AMERICAN SOCIETY OF HEMATOLOGY 2012 second_quarter MED Research in hematology. Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 30000   0 0 2012-07-16T16:55:51.250000-04:00
1264889 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 2fe1967b-9f42-46b5-9c0c-65b2776de717 Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 NATIONAL HEMOPHILIA FOUNDATION 2012 second_quarter MED Hemophilia research, prevention, surveillance and service programs and issues. HR1919 Bleeding Disorders Screening Awareness and Further Education Act of 2011 Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 50000   0 0 2012-07-16T17:00:00.737000-04:00
1264895 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. a7e78f06-f20a-4cdf-9ed3-f0ab6a9e261f Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 ASSOCIATION OF AMERICA'S BLOOD BANKS 2012 second_quarter MED Blood safety and management issues. HHS Advisory Committee on Blood Safety and Availability. Research related to Biovigilance. Centers For Disease Control & Prevention (CDC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2012-07-16T17:04:04.843000-04:00
1264988 MCDERMOTT WILL & SCHULTE LLP e38e2763-3c34-45cf-b6d6-3b3ae0ef21c1 Q2 MCDERMOTT WILL & SCHULTE LLP 24338 MAYO CLINIC 2012 second_quarter MED Address the safety, health and environmental concerns regarding the transport by railroad of hazardous commodities and coal traffic near the Rochester, Minnesota Mayo Clinic facility. The multi-year Surface Transportation Authorization Act and the House THUD Subcommittee Transportation, Housing and Urban Development Appropriations Bill. HOUSE OF REPRESENTATIVES,SENATE,Transportation, Dept of (DOT) 30000   0 0 2012-07-16T17:30:45.413000-04:00
1265014 MCDERMOTT WILL & SCHULTE LLP 1fde7ce9-244b-49b6-af75-b2d7f5654044 Q2 MCDERMOTT WILL & SCHULTE LLP 24338 ISIS PHARMACEUTICALS 2012 second_quarter MED Promote policies and legislation that foster medical research and development, as well as the antisense drug technology which promises relief from potential diseases including cancer, AIDs and diabetes. Specifically, work on patent reform legislation, including S. 23 and H.R. 1249. HOUSE OF REPRESENTATIVES,SENATE     0 0 2012-07-16T17:35:55.847000-04:00
1265219 THE FEDERAL GROUP, INC. bfdad10a-a92d-4b70-845a-d206138728c9 Q2 THE FEDERAL GROUP, INC. 51104 AMERICAN SOCIETY FOR CLINICAL LABORATORY SCIENCE 2012 second_quarter MED Issues relating to the regulation of clinical laboratories through the Clinical Laboratory Improvement Act. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2012-07-16T23:58:38.143000-04:00
1265222 THE FEDERAL GROUP, INC. 94d66c05-b084-4b3f-8fa5-45e54fb36360 Q2 THE FEDERAL GROUP, INC. 51104 AMERICAN COLLEGE OF RADIOLOGY 2012 second_quarter MED Issues relating to mammography screening and standards. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2012-07-17T00:35:39.387000-04:00
1265377 THE CJR GROUP, INC. 0022c0f5-a80c-43e4-bbf5-a7cd55eebbe3 Q2 THE CJR GROUP, INC. 288293 UNIVERSITY HOSPITALS HEALTH SYSTEM 2012 second_quarter MED Medical issues relating to hospitals HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-07-17T09:26:39.060000-04:00
1265389 THE CJR GROUP, INC. af2ed26d-7f24-47f5-b045-8434c9fdef43 Q2 THE CJR GROUP, INC. 288293 STERIS CORPORATION 2012 second_quarter MED Biomedical issues HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2012-07-17T09:29:43.257000-04:00
1265422 THE NATIONAL ALLIANCE FOR EYE AND VISION RESEARCH bfe630c5-0bd0-41d2-9746-f5113dcca5e5 Q2 THE NATIONAL ALLIANCE FOR EYE AND VISION RESEARCH 314055 THE NATIONAL ALLIANCE FOR EYE AND VISION RESEARCH 2012 second_quarter MED Support for the National Eye Institute at the National Institues of Health; Support for medical research programs at the Department of Defense HOUSE OF REPRESENTATIVES,SENATE   61500 0 0 2012-07-17T09:49:00.690000-04:00
1265470 MEHLMAN CONSULTING, INC. ec4b750a-190e-4870-8e5e-beadf4bcfe38 Q2 MEHLMAN CONSULTING, INC. 284950 MAYO CLINIC 2012 second_quarter MED NIH appropriations Clinical laboratory reimbursement Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2012-07-17T10:02:23.130000-04:00
1265632 CHILDREN'S HOSPITAL BOSTON d3047021-3572-4b0c-8344-728ab531a088 Q2 CHILDREN'S HOSPITAL BOSTON 9066 CHILDREN'S HOSPITAL BOSTON 2012 second_quarter MED Pediatric research issues including clinical effectiveness, development of pediatric research consortia, and specific disease areas. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE   130000 0 0 2012-07-17T10:47:46.887000-04:00
1266021 AMERICAN SOCIETY FOR MICROBIOLOGY f3fbccb5-dba2-4bf7-945a-80778e42ae31 Q2 AMERICAN SOCIETY FOR MICROBIOLOGY 3355 AMERICAN SOCIETY FOR MICROBIOLOGY 2012 second_quarter MED Antimicrobial Resistance New Drugs Food and Drug Administration Fee Bill S. 3187 HOUSE OF REPRESENTATIVES,SENATE     0 0 2012-07-17T11:55:29.587000-04:00
1266169 FABIANI & COMPANY 4490dae3-6ebf-44d8-b2a3-896f1384c19d Q2 FABIANI & COMPANY 72576 ACORDA THERAPEUTICS, INC. 2012 second_quarter MED Educate staff about Acordas products and research interests. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2012-07-17T13:09:51.487000-04:00
1266176 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 79271210-134a-4b94-aac8-083981f42251 Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 ONYX PHARMACEUTICALS 2012 second_quarter MED Innovation in biotechnology; patient access to treatments; FDA accelerated approval process; orphan drugs for rare diseases, health disparities, drug shortages. HR 4132 Faster Access to Specialized Treatments (FAST) Act; S.2113 Transforming the Regulatory Environment to Accellerate Access to Treatments (TREAT) Act; HR 2245/S.296: Preserving Access to Lifesaving Medications Act; S.3187, Food and Drug Administration Safety and Innovation Act Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 30000   0 0 2012-07-17T13:09:54.003000-04:00
1266231 VAN SCOYOC ASSOCIATES ba191897-24f8-4a03-a4f9-0b194e887668 Q2 VAN SCOYOC ASSOCIATES 39837 TULANE UNIVERSITY 2012 second_quarter MED No lobbying activity. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2012-07-17T13:19:21.750000-04:00
1266266 FABIANI & COMPANY 3a23fbcd-0e8e-403a-8a8c-fa8362cf092c Q2 FABIANI & COMPANY 72576 MEDICAGO INC. 2012 second_quarter MED Funding to advance technology to support public health preparedness applications. Defense, Dept of (DOD) 30000   0 0 2012-07-17T13:24:41.677000-04:00
1266343 MCDERMOTT WILL & SCHULTE LLP a8570a0a-4c86-43cf-beaa-ca89ca279fe9 Q2 MCDERMOTT WILL & SCHULTE LLP 24338 COALITION FOR 21ST CENTURY MEDICINE 2012 second_quarter MED Issues concerning regulation of laboratory tests. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2012-07-17T13:38:20.117000-04:00
1266380 MCDERMOTT WILL & SCHULTE LLP f55ce1d5-1418-4833-95d3-44cf388b9112 Q2 MCDERMOTT WILL & SCHULTE LLP 24338 GENOMIC HEALTH INC 2012 second_quarter MED FDA regulation of laboratory-developed tests. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2012-07-17T13:47:41.600000-04:00
1266870 TCH GROUP, LLC 66c8540e-a000-4105-ad84-19be7bd39ac7 Q2 TCH GROUP, LLC 51478 AMGEN USA INC 2012 second_quarter MED Reauthorization of the Prescription Drug User Fee Act (PDUFA) HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2012-07-17T15:39:51.517000-04:00
1267011 FABIANI & COMPANY 6cf9d96f-a604-43c7-9b03-82677433ceb7 2T FABIANI & COMPANY 72576 TARAXOS 2012 second_quarter MED Clinical research supporting development of topical pain medication for the DoD and veteran populations. Veterans Affairs, Dept of (VA)     0 1 2012-07-17T16:03:50.563000-04:00
1267103 LATHAM & WATKINS LLP 2b6d65c5-d0cd-4398-82e3-83d53acc90a6 Q2 LATHAM & WATKINS LLP 22201 BOSTON SCIENTIFIC CORPORATION 2012 second_quarter MED Congressional oversight of the Food and Drug Administration. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2012-07-17T16:20:32.937000-04:00
1267386 WHITMER & WORRALL, LLC 30208b09-8dd7-4c1c-8ff3-f37913270f9b Q2 WHITMER & WORRALL, LLC 292892 NEURO KINETICS 2012 second_quarter MED Issues related to Traumatic Brain Injury (TBI). Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) 10000   0 0 2012-07-17T17:00:46.267000-04:00
1267442 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 4bce38f8-6d57-4221-8dd2-de8cf637c9fd Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 CRESCENDO BIOSCIENCE INC. 2012 second_quarter MED Biomedical research, treatment of rheumatoid arthritis, public-private partnerships, oversight and reimbursement of laboratory testing. HR 436, Protect Medical Innovation Act HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 10000   0 0 2012-07-17T17:09:13.237000-04:00
1267810 NATIONAL PSORIASIS FOUNDATION 2924ad01-c472-4907-8cd2-5b045940efe8 Q2 NATIONAL PSORIASIS FOUNDATION 314658 NATIONAL PSORIASIS FOUNDATION 2012 second_quarter MED H.R.2033: The Psoriasis and Psoriatic Arthritis Research, Cure and Care Act of 2011 S.1107: The Psoriasis and Psoriatic Arthritis Research, Cure and Care Act of 2011 SEC. 3. NATIONAL PSORIASIS AND PSORIATIC ARTHRITIS DATA COLLECTION. (a) In General- The Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention, is authorized to undertake psoriasis and psoriatic arthritis data collection efforts, including incorporating questions into public health surveys, questionnaires, and other databases in existence as of the date of the enactment of this Act to collect information, with respect to psoriasis and psoriatic arthritis, regarding-- (1) the prevalence of psoriasis and psoriatic arthritis in the United States; (2) the age of onset; (3) health-related quality of life; (4) health care utilization; (5) burden of such disease (such as with respect to employment); (6) direct and indirect costs; (7) health disparities, including with respect to age, gender, race, and ethnicity; and (8) comorbidities and the natural history of such disease. Such data collection efforts may include the consideration and development of a patient registry, which would include individuals of all ages. (b) Authorization of Appropriations- To carry out subsection (a), there are authorized to be appropriated $1,500,000 for each of fiscal years 2012 through 2017. SEC. 4. SENSE OF CONGRESS FOR COLLABORATIVE INTERDISCIPLINARY RESEARCH ON PSORIASIS AND PSORIATIC ARTHRITIS AND COMORBID CONDITIONS. It is the sense of the Congress that-- (1) the psoriasis research community has made significant strides in proving the seriousness of psoriasis as an autoimmune disease and in advancing the identification of commonalities between psoriasis and other diseases; (2) the nonprofit and private sector psoriasis research communities are to be commended for planning a multidisciplinary scientific meeting in 2012 to discuss future directions of psoriasis and comorbid research, identify initiatives nece… HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE   120000 0 0 2012-07-17T19:14:13.607000-04:00
1268049 THE NORMANDY GROUP, LLC 5221d9ea-75f4-4235-9630-58b5908ffd49 Q2 THE NORMANDY GROUP, LLC 306636 CENTER FOR DISEASE DETECTION, LLC 2012 second_quarter MED Seek assistance from Dept. of Commerce, Dept. of State in effort to expand medical testing in foreign countries. Commerce, Dept of (DOC),State, Dept of (DOS) 30000   0 0 2012-07-18T09:25:26.163000-04:00
1268123 POLICY DIRECTIONS INC. 170322be-ea43-4edf-aa06-8e7fc48a453b Q2 POLICY DIRECTIONS INC. 31747 BAYLOR COLLEGE OF MEDICINE 2012 second_quarter MED S. 606 and HR 3059- Creating Hope Act of 2011 - issues related to neglected tropical disease research and treatment. HR 528 - Neglected Infections of Impoverished Americans Act of 2011. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-07-18T09:42:55.053000-04:00
1268173 POLICY DIRECTIONS INC. a75e217a-f202-4240-a32e-32c5257bd282 Q2 POLICY DIRECTIONS INC. 31747 COVANCE INC 2012 second_quarter MED No Bills. Issues related to FDA regulatory requirements for product testing. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2012-07-18T09:50:12.117000-04:00
1268715 FAEGRE BAKER DANIELS CONSULTING 9fe998bb-387e-4b41-8bea-dd7b1d8ecd79 Q2 FAEGRE BAKER DANIELS CONSULTING 34158 COALITION FOR EXCELLENCE IN MEDICATION MONITORING 2012 second_quarter MED Medicare and Medicaid coverage and payment HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-07-18T11:19:37.597000-04:00
1268827 FABIANI & COMPANY 2c69d66f-3f98-40b1-9292-5bc810218a8e Q2 FABIANI & COMPANY 72576 ZIOPHARM ONCOLOGY, INC. 2012 second_quarter MED Educated members of the House of Representatives on the importance of encouraging innovation in rare cancer drug development. HOUSE OF REPRESENTATIVES 50000   0 0 2012-07-18T11:32:26.947000-04:00
1268930 PARRY, ROMANI, DECONCINI & SYMMS 2fbc5189-4f74-4bea-a23c-57d7e3315b3f Q2 PARRY, ROMANI, DECONCINI & SYMMS 30792 SANOFI US SERVICES INC (FORMERLY KNOWN AS SANOFI-AVENTIS U S INC ) 2012 second_quarter MED General discussions regarding the rauthorization of the Prescription Drug User Fee Act (PDUFA), S. 3187 and H.R. 5651; and education and awareness of vaccine production and infrastructure needs. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-07-18T11:46:14.890000-04:00
1269059 DESIMONE CONSULTING, LLC 827f7025-0953-4ddd-8f2c-a34b2e2ac380 Q2 DESIMONE CONSULTING, LLC 400931695 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) 2012 second_quarter MED Issues related to access to medicines and other medical therapies, the development of new medical therapies and regulatory matters regarding the bio-pharmaceutical industry. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2012-07-18T12:00:56.457000-04:00
1269958 THE CORMAC GROUP, LLC 225a4edf-df46-4dee-9b2f-befc7ede85ea Q2 THE CORMAC GROUP, LLC 66773 MIAMI JEWISH HEALTH SYSTEMS 2012 second_quarter MED HHS Appropriations, health care facilities, IT funding for nursing homes, federal grants and veterans programs Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2012-07-18T14:07:46.337000-04:00

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);
Powered by Datasette · Queries took 1780.844ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API